View in EDS HTML Full Text PDF Full Text

End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy—Modified N7 Regimen with Dinutuximab Beta.

Saved in:
Bibliographic Details
Title: End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy—Modified N7 Regimen with Dinutuximab Beta.
Authors: Lu, Evelyn R.1,2 (AUTHOR), Hoo, Calvin P. L.1,2 (AUTHOR), Cheung, Ho Ming3 (AUTHOR), Wong, I. W. C.3,4 (AUTHOR), Fung, K. F. Kevin4,5 (AUTHOR), Chang, Sylvia L. Y.1 (AUTHOR), Lee, Anselm C. W.1,2 (AUTHOR), Fu, Eric C. H.1,3 (AUTHOR), Ku, Dennis T. L.1,4 (AUTHOR), Yau, Jeffrey P. W.1,5 (AUTHOR), Shing, Matthew M. K.1 (AUTHOR), Mak, Christy Y. K.1 (AUTHOR), Liu, Anthony P. Y.1,5 (AUTHOR), Chan, Godfrey C. F.1 (AUTHOR) gcfchan@hku.hk
Source: Cancers. Mar2026, Vol. 18 Issue 6, p1028. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers18061028